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From inception until today the field of psychiatry has relied extensively on subjective information to 
determine diagnosis, illness activity and assess treatment responses.  Unlike many other medical 
disciplines, the information provided by patients or relatives in clinical interviews or collected through 
scales, continues to be the main guide for both research and clinical practice. Most of these 
assessments are brief cross-sectional snapshots of altered behaviours, mood or thoughts, which 
provide only a partial and under-representative picture of the total illness course upon which the 
whole psychiatric taxonomy is currently based.  
Self-reports of people suffering from mental disorders or their relative’s perspective is of paramount 
importance to understanding of these illnesses, but these are not exempt from the inherent 
limitations of human cognition under both normal and distressing circumstances (e.g., confirmation 
bias, lack of insight, misinterpretations, etc). Clinician rated measures are subject to the same 
influences.  Additionally, there is, even within leading research groups, a diversity in the application 
of diagnostic criteria as well as variability in diagnostic criteria and scales inter-rater reliability.  These 
limitations are likely to be principal reasons contributing to the slow development of more specific 
new treatments along with the scarcity of tools available to predict responses and personalize the 
currently existing ones.   
To overcome these issues, a huge research effort to find and make available reliable auxiliary objective 
diagnostic methods (such as peripheral, genetic or neuroimaging biomarkers) which might 
complement the subjective information has been mounted. However, at least until now, almost none 
of these methods have progressed to real-world clinical practice. Moreover, contrary to initial 
optimism, there is growing evidence of numerous biases in the body of scientific evidence about 
biomarkers published so far about the most disabling mental disorders (Carvalho et al., 2016; Prata et 
al., 2014). 
At the same time as the slow progress of psychiatric research over the last few decades, there has 
been an exponential growth of the Internet, now reaching almost all the most remote populations of 
the world, which has opened seemingly endless possibilities to the medical field in general including 
psychiatry. This has already extended mental health care services and interventions at lower costs 
over video-conferencing and web-based platforms.  More recently, this enormous potential was 
further enhanced with the widespread and ubiquitous access to the Internet through mobile devices, 
especially smartphones.  These increasingly cheaper and accessible devices have been adopted as 
essential companions to our daily routine and are no longer limited to just communication but now 
involve entertainment, social networking, shopping and all kind of common daily activities.  Attempts 
have been made to adapt and deliver psychological treatments through user-friendly apps for a variety 
of mental health disorders.  However, the exact role of these apps, either as standalone, companion 
or adjunctive interventions to face-to-face treatments, is still a matter of discussion.   
Information from embedded sensors may be passively and continuously captured by smartphones 
and uploaded to data servers. These vast amounts of real-time information can reveal many novel and 
objective aspects of our behaviour which can be used for diverse aims and enables the design of 
predictive models. Until now most of this information has been used by companies for commercial, 
marketing and content personalization purposes on a massive scale.  However, if the same principles 
were to be applied as “digital behavioural biomarkers”, also known as “digital phenotypes”, this might 
complement clinical subjective measures and thus potentially improve mental health diagnosis and 
treatments (Hidalgo-Mazzei et al., 2018; Insel, 2018).  
 This brave new world has been foretold by several researchers during the last few years.  Notably 
however, the attempts to evaluate these approaches have been delayed due to limitations inherent 
to academic research, principally more limited funding and technical resources in comparison to the 
private corporate sector.  Nonetheless, progress is being made.  In this new study (Faurholt-Jepsen et 
al., 2018), along with previous publications in the field by the same authors, Faurholt-Jepsen et al. 
have confirmed the enormous potential of smartphones for mental health research and clinical 
practice. The extraordinary results of this study challenge previous assumptions about specific 
smartphone usage patterns of bipolar disorder patients across different mood states in comparison 
to healthy controls. It is important to note that the smartphone-based diagnostic marker evaluated 
by the authors, which didn´t reach adequate levels of specificity (0.39), did show an overall sensitivity 
(0.92) comparable to the most widely used diagnostic screening tools for bipolar disorder such as the 
hypomania checklist (HCL-32), the mood disorder questionnaire (MDQ) and the bipolar spectrum 
diagnostic scale (BSDS).  These results suggest that automatically generated objective data can reveal 
unknown aspects about mental illnesses and enable widely accessible screening tools which 
complement diagnostic processes.  
This paper reports another promising step on the long march towards routine use of smartphones as 
complements to other sources of data in mental health research and clinical practice.  Smartphones 
might allow us to better capture the whole clinical picture and trajectory of these complex disorders 
and facilitate the development of much needed better, accessible and tailored treatments. 
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